Hexarelin: Patient Information & Safety Notes
Also known as Examorelin, EP-23905
Other names: examorelin, ep-23905
Hexarelin is a synthetic hexapeptide that acts on the growth hormone secretagogue receptor (GHSR/ghrelin receptor) to stimulate pituitary growth hormone release. It has been studied in limited human trials but is NOT approved by the FDA for any indication.
In plain language
What Hexarelin is used for
- Studied in research settings for possible effects on growth-hormone secretion
Taking this medicine
How it is administered
- Subcutaneous injection
Read before you decide
Risks and precautions
Risks and warnings
- Injection site irritation
- Water retention
- Potential cortisol elevation
Who should not take it
- Active or past malignancy
- Pituitary disorders
Common questions
Patient questions
Is hexarelin FDA-approved?
No. Hexarelin is not FDA-approved for any indication. It is a research compound; its safety and efficacy have not been established through the FDA approval process.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.